ClinicalTrials.gg
CompletedNCT04638127Updated Jun 27, 2025Results posted

PREEMIE PROGRESS: A Family Management Program for Parents of Preterm Infants

An interventional study of PREEMIE PROGRESS and Attention Control in Premature Infant Disease, Family Research and Parent-Child Relations, sponsored by University of Cincinnati. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-27.

Primary conditionMultiple Chronic ConditionsRegistry: Patient ParticipationReclassifiedWhy we changed it
Registry
Patient Participation — the first condition term the registry derived for this study.
ClinicalTrials.gg
Multiple Chronic Conditions
Why
  1. Patient Participation is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Multiple Chronic Conditions.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Cincinnati · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to refine and pilot test a mobile health (mHealth), video-based family management program for parents of preterm infants hospitalized in the Neonatal Intensive Care Unit (NICU). By moving beyond the basic infant care tasks taught by parenting programs and instead comprehensively training parents to use evidence-based family management skills, we hypothesize that our intervention, called PREEMIE PROGRESS, will better equip parents to meet the chronic, complex healthcare needs of their preterm infant.

Read the detailed description

Increasing numbers of very preterm infants are surviving and have chronic, complex healthcare needs due to prematurity. These infants experience increased healthcare utilization, long durations of stay in the Neonatal Intensive Care Unit (NICU), and are at high risk of developing prematurity-related complications. As a result, their care is complex, and families need structured training to effectively understand, monitor, and manage their infant's care. PREEMIE PROGRESS is an innovative, video-based intervention that applies evidence-based family management theories to better equip parents to meet the chronic, complex healthcare needs of their preterm infant. This research aims to 1) refine a novel family management program, called PREEMIE PROGRESS, through iterative usability and acceptability testing and 2) test feasibility and acceptability of the refined intervention and study procedures in a pilot randomized controlled trial. This project will use implementation science tools and approaches to refine the intervention and study procedures to ensure that PREEMIE PROGRESS addresses key program elements that will be important for future adoption and implementation in NICU settings. We anticipate that the intervention will decrease parent anxiety and depression, increase infant weight gain and receipt of mother's milk, and reduce neonatal healthcare utilization. The long-term goal of this project is to develop, test, and translate into NICU practice an efficacious family management intervention for parents of preterm infants. Dr. Weber will significantly advance nursing science through this project by obtaining preliminary feasibility and acceptability data for a scalable and sustainable intervention to facilitate family management and improve parent-infant health outcomes.

02

Conditions studied

  • Premature Infant Disease
  • Family Research
  • Parent-Child Relations
  • Self Efficacy
  • Patient Engagement
  • Patient Empowerment
  • Parenting
  • Chronic Conditions, Multiple

Browse trials for

Keywords

  • neonatal intensive care unit
  • prematurity
  • family management
  • self-management
  • patient education
03

In context

Multiple Chronic Conditions Reclassified

89 studies on the registry are indexed under Multiple Chronic Conditions; 16 are open to participants now.

This study's enrollment of 64 is below the median of 128 across 71 interventional studies indexed under Multiple Chronic Conditions.

Browse Multiple Chronic Conditions studies →

Lead sponsor

University of Cincinnati is the lead sponsor of 324 studies on the registry; 42 are open to participants now.

Of its 24 completed or terminated interventional studies of FDA-regulated products, 15 (63%) have results posted.

Compared within Multiple Chronic Conditions, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Patient Participation. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English-speaking parents
  • Parents preterm infants born 25 0/7-31 6/7 weeks gestational age (GA)
  • Parents who had a singleton or twin birth
  • Parents 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  • Mothers too ill (serious maternal complications, medications that impact alertness/ orientation) to provide
  • Infants with imminent or probable death based on the healthcare team's judgement
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
64 participants (actual)

Study arms

  • Experimental
    PREEMIE PROGRESS

    PREEMIE PROGRESS is an innovative, video-based intervention that applies evidence-based family management theories to better equip parents to meet the chronic, complex healthcare needs of their preterm infant.

    Behavioral: PREEMIE PROGRESS

  • Active comparator
    Attention Control

    To maintain their attention, control parents will view "Welcome Videos" that explain hand hygiene, visitor IDs, parking, etc. on their mobile devices.

    Behavioral: Attention Control

Interventions

  • BehavioralPREEMIE PROGRESS

    PREEMIE PROGRESS is a video-based training program for parents of preterm infants hospitalized in the neonatal intensive care unit (NICU).

  • BehavioralAttention Control

    usual care and welcome videos

06

What researchers measure

Primary outcomes

  1. Maternal Self-Rating of Depression

    Patient-Reported Outcomes Measurement Information System (PROMIS) 8a Higher scores indicate higher levels of depression: T-score: standardized score mean of 50 and standard deviation (SD) of 10 The T-score is a score on a scale where 50 represents the average for the US general population (minimum of 8a Short Form is 38.2, maximum is 81.3). Each 10-point change represents one standard deviation (SD). A T-score of 75 or greater indicates clinically significant, severe symptoms.

    Time frame: Assessed at Baseline14 days post-baseline (T2), 28 days post-baseline (T3), and 30 days after infant discharge from the NICU (T4). Change from Baseline to 30 days after infant discharge from the NICU (T4) Reported.

  2. Maternal Self-Rating of Anxiety

    Patient-Reported Outcomes Measurement Information System (PROMIS) 8a Higher scores indicate higher levels of anxiety: T-score: standardized score mean of 50 and standard deviation (SD) of 10 The T-score is a score on a scale where 50 represents the average for the US general population (minimum of 8a Short Form is 38.2, maximum is 81.3). Each 10-point change represents one standard deviation (SD). A T-score of 75 or greater indicates clinically significant, severe symptoms.

    Time frame: Assessed at Baseline, 14 days post-baseline (T2), 28 days post-baseline (T3), and 30 days after infant discharge from the NICU (T4). Change from Baseline to 30 days after infant discharge from the NICU (T4) Reported.

  3. Receipt of Exclusive Mother's Human Milk

    Number of infants receiving exclusive mother's milk were recorded and percent of infants was calculated from the total number number of infants receiving enteral feeds. Infants were marked as receiving exclusive mother's milk if all feeds were mother's milk (i.e., infant did not receive donor milk or formula). Percent of infants receiving exclusive mother's milk = Number of infants receiving exclusive mother's milk / Number of infants on enteral feeds

    Time frame: Assessed at Baseline, 14 days post-baseline (T2), 28 days post-baseline (T3).

  4. Change in Fenton 2013 Growth Calculator Z-scores From Birth to 36 Weeks Corrected Gestational Age

    Change in Z score weight from birth to 36 weeks corrected gestational age (or at discharge if earlier) was calculated using PediTools Fenton 2013 Growth Calculator for Preterm Infants. Z-scores are the number of standard deviations above or below a growth chart's center (mean) curve. A Fenton preterm growth chart Z-score of 0 means the infant's growth measurement (e.g., weight) is at the average (mean) for their age and sex. Changes in Z-scores tell if a second measurement is closer or further away from the growth chart center than the previous measurement. Change in Z-score of 0 means the infant's percentile on the growth chart did not change. Higher Z scores indicate increased growth acceleration. The Academy of Nutrition and Dietetics considers Z score changes less than -0.8 to indicate growth failure. Normal growth during NICU hospitalization is defined as a z-score change of -0.79 to 0.79. Z score Δ = \[Zscore at 36 weeks corrected gestational age\] - \[Zscore at birth\]

    Time frame: Z scores were calculated at 36 weeks corrected gestational age (or at discharge if earlier) and at birth.

  5. NICU Length of Stay

    Days of NICU hospitalization (calculated from days between date of birth to date of discharge from NICU)

    Time frame: Date of NICU discharge will be assessed until study completion, with maximum of 1 year

  6. Infant Hospital Readmissions and Emergency Department Visits Within 30 Days of Infant Discharge - YES Response

    The infant's electronic health record was reviewed for hospital readmissions and emergency department visits within 30 days of infant discharge. Mothers were also asked "Did your infant have any re-hospitalizations or emergency department visits within 30 days of discharge?", to ensure all rehospitalizations and ED visits were captured.

    Time frame: Thirty days after infant discharge from the NICU.

07

Results

Posted Jun 27, 2025

Participant flow

Participant flow — Overall Study
MilestonePREEMIE PROGRESSAttention Control
Started3331
Completed1626
Not completed175

Outcome measures

PrimaryMaternal Self-Rating of Depression

Patient-Reported Outcomes Measurement Information System (PROMIS) 8a Higher scores indicate higher levels of depression: T-score: standardized score mean of 50 and standard deviation (SD) of 10 The T-score is a score on a scale where 50 represents the average for the US general population (minimum of 8a Short Form is 38.2, maximum is 81.3). Each 10-point change represents one standard deviation (SD). A T-score of 75 or greater indicates clinically significant, severe symptoms.

Time frame:
Assessed at Baseline14 days post-baseline (T2), 28 days post-baseline (T3), and 30 days after infant discharge from the NICU (T4). Change from Baseline to 30 days after infant discharge from the NICU (T4) Reported.
Reported as:
Mean · T-score mean changes
Maternal Self-Rating of Depression
T-score mean changesPREEMIE PROGRESSAttention Control
T2 - Baseline-3.75 ± 1.70-4.08 ± 1.42
T3 - Baseline-2.21 ± 1.58-2.50 ± 1.35
T4 - Baseline-4.08 ± 1.42-3.75 ± 1.70
PrimaryMaternal Self-Rating of Anxiety

Patient-Reported Outcomes Measurement Information System (PROMIS) 8a Higher scores indicate higher levels of anxiety: T-score: standardized score mean of 50 and standard deviation (SD) of 10 The T-score is a score on a scale where 50 represents the average for the US general population (minimum of 8a Short Form is 38.2, maximum is 81.3). Each 10-point change represents one standard deviation (SD). A T-score of 75 or greater indicates clinically significant, severe symptoms.

Time frame:
Assessed at Baseline, 14 days post-baseline (T2), 28 days post-baseline (T3), and 30 days after infant discharge from the NICU (T4). Change from Baseline to 30 days after infant discharge from the NICU (T4) Reported.
Reported as:
Mean · T-score
Maternal Self-Rating of Anxiety
T-scorePREEMIE PROGRESSAttention Control
T2-Baseline-3.08 ± 1.74-1.96 ± 1.52
T3-Baseline2.87 ± 1.77-3.91 ± 1.53
T4-Baseline-4.67 ± 1.59-7.54 ± 1.93
PrimaryReceipt of Exclusive Mother's Human Milk

Number of infants receiving exclusive mother's milk were recorded and percent of infants was calculated from the total number number of infants receiving enteral feeds. Infants were marked as receiving exclusive mother's milk if all feeds were mother's milk (i.e., infant did not receive donor milk or formula). Percent of infants receiving exclusive mother's milk = Number of infants receiving exclusive mother's milk / Number of infants on enteral feeds

Time frame:
Assessed at Baseline, 14 days post-baseline (T2), 28 days post-baseline (T3).
Reported as:
Count of participants · Participants
Receipt of Exclusive Mother's Human Milk
ParticipantsPREEMIE PROGRESSAttention Control
Baseline1718
T21315
T31410
PrimaryChange in Fenton 2013 Growth Calculator Z-scores From Birth to 36 Weeks Corrected Gestational Age

Change in Z score weight from birth to 36 weeks corrected gestational age (or at discharge if earlier) was calculated using PediTools Fenton 2013 Growth Calculator for Preterm Infants. Z-scores are the number of standard deviations above or below a growth chart's center (mean) curve. A Fenton preterm growth chart Z-score of 0 means the infant's growth measurement (e.g., weight) is at the average (mean) for their age and sex. Changes in Z-scores tell if a second measurement is closer or further away from the growth chart center than the previous measurement. Change in Z-score of 0 means the infant's percentile on the growth chart did not change. Higher Z scores indicate increased growth acceleration. The Academy of Nutrition and Dietetics considers Z score changes less than -0.8 to indicate growth failure. Normal growth during NICU hospitalization is defined as a z-score change of -0.79 to 0.79. Z score Δ = \[Zscore at 36 weeks corrected gestational age\] - \[Zscore at birth\]

Time frame:
Z scores were calculated at 36 weeks corrected gestational age (or at discharge if earlier) and at birth.
Reported as:
Median · Z-score
Change in Fenton 2013 Growth Calculator Z-scores From Birth to 36 Weeks Corrected Gestational Age
Z-scorePREEMIE PROGRESSAttention Control
Change in Fenton 2013 Growth Calculator Z-scores From Birth to 36 Weeks Corrected Gestational Age-0.8 (-1.36 to -0.51)-0.72 (-1.11 to -0.39)
PrimaryNICU Length of Stay

Days of NICU hospitalization (calculated from days between date of birth to date of discharge from NICU)

Time frame:
Date of NICU discharge will be assessed until study completion, with maximum of 1 year
Reported as:
Mean · days
NICU Length of Stay
daysAttention ControlPREEMIE PROGRESS
NICU Length of Stay68.3 ± 36.357.2 ± 23.4
PrimaryInfant Hospital Readmissions and Emergency Department Visits Within 30 Days of Infant Discharge - YES Response

The infant's electronic health record was reviewed for hospital readmissions and emergency department visits within 30 days of infant discharge. Mothers were also asked "Did your infant have any re-hospitalizations or emergency department visits within 30 days of discharge?", to ensure all rehospitalizations and ED visits were captured.

Time frame:
Thirty days after infant discharge from the NICU.
Reported as:
Count of participants · Participants
Infant Hospital Readmissions and Emergency Department Visits Within 30 Days of Infant Discharge - YES Response
ParticipantsAttention ControlPREEMIE PROGRESS
Infant Hospital Readmissions and Emergency Department Visits Within 30 Days of Infant Discharge - YES Response24

Adverse events

Collected over Assessed at Baseline, 14 days post-baseline (T2), 28 days post-baseline (T3), and 30 days after infant discharge from the NICU (T4).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Attention Control0/31 (0%)0/31 (0%)3/31 (9.7%)
PREEMIE PROGRESS1/34 (2.9%)0/34 (0%)0/34 (0%)
Most frequent other events
Most frequent other events
EventAttention ControlPREEMIE PROGRESS
Psychological Distress, Clinical significant Anxiety or DepressionPsychiatric disorders3/310/34

Baseline characteristics

Age, Continuous
Age, Continuous(years)PREEMIE PROGRESSAttention ControlTotal
Mean29.1 ± 6.730.5 ± 4.329.8 ± 5.7
Age, Customized
Age, Customized(weeks)PREEMIE PROGRESSAttention ControlTotal
Infant gestation at birth (wks)29.2 ± 1.829.3 ± 2.129.2 ± 1.9
Sex: Female, Male
Sex: Female, Male(Participants)PREEMIE PROGRESSAttention ControlTotal
Female16824
Male172340
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)PREEMIE PROGRESSAttention ControlTotal
Hispanic or Latino011
Not Hispanic or Latino302959
Unknown or Not Reported314
Race (NIH/OMB)
Race (NIH/OMB)(Participants)PREEMIE PROGRESSAttention ControlTotal
American Indian or Alaska Native000
Asian011
Native Hawaiian or Other Pacific Islander000
Black or African American131023
White181735
More than one race224
Unknown or Not Reported011
Region of Enrollment
Region of Enrollment(Participants)PREEMIE PROGRESSAttention ControlTotal
United States333164
Birth weight (g)
Birth weight (g)(grams)PREEMIE PROGRESSAttention ControlTotal
Mean1253.9 ± 392.41286.2 ± 359.21269 ± 374
Income (in $10,000)
Income (in $10,000)(Annual income in $10,000)PREEMIE PROGRESSAttention ControlTotal
Mean47000 ± 3900044000 ± 3900045400 ± 39000

2 further baseline measures are reported on the registry.

08

Study locations

1 site
  • University of Cincinnati
    Cincinnati, Ohio 45221, United States
09

References and documents

Publications

  • Weber A, Bakas T, Oudat Q, Parikh NA, Lambert J, Tubbs-Cooley HL, Rice J, Voos K, Rota M, Kaplan HC. An Internet-Based and Mobile Family Management Intervention for Mothers of Very Preterm Infants Hospitalized in the Neonatal Intensive Care Unit (the Preemie Progress Program): Pilot Randomized Controlled Trial. JMIR Form Res. 2025 May 21;9:e66073. doi: 10.2196/66073. PubMed 40397935 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04638127
Responsible party
Ashley Weber (Assistant Professor, University of Cincinnati) — Principal investigator
First posted
Nov 20, 2020
Start date
May 17, 2022
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Results posted
Jun 27, 2025
Last update
Jun 27, 2025

Study contacts

Ashley M Weber, PhD, RN, RNC-NIC
principal investigator · University of Cincinnati

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion